These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7817796)

  • 21. Differences in osteocyte density and bone histomorphometry between men and women and between healthy and osteoporotic subjects.
    Mullender MG; Tan SD; Vico L; Alexandre C; Klein-Nulend J
    Calcif Tissue Int; 2005 Nov; 77(5):291-6. PubMed ID: 16307389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The different routes of administration and the effect of hormone replacement therapy on osteoporosis.
    Christiansen C
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):152S-156S. PubMed ID: 7958010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
    Chapurlat R; Meunier PJ
    Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Normal bone remodelling--what can go wrong in osteoporosis?].
    Midtby M; Magnus JH
    Tidsskr Nor Laegeforen; 1998 Feb; 118(4):552-7. PubMed ID: 9520583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vertebral endplate morphology follows bone remodeling principles.
    Grosland NM; Goel VK
    Spine (Phila Pa 1976); 2007 Nov; 32(23):E667-73. PubMed ID: 17978642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical effects of bisphosphonates in involutional osteoporosis.
    Ott SM
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S597-606. PubMed ID: 8122531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis.
    Storm T; Steiniche T; Thamsborg G; Melsen F
    J Bone Miner Res; 1993 Feb; 8(2):199-208. PubMed ID: 8442438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mass and bone modelling markers in hypertensive postmenopausal women.
    Pérez-Castrillón JL; Justo I; Silva J; Sanz A; Igea R; Escudero P; Pueyo C; Diaz C; Hernández G; Dueñas A
    J Hum Hypertens; 2003 Feb; 17(2):107-10. PubMed ID: 12574788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The impact of statin therapy on bone density changes in postmenopausal women].
    Svejda P; Soska V; Soucek M
    Vnitr Lek; 2007 Oct; 53(10):1064-70. PubMed ID: 18072431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Simulation on the process of female osteoporosis and its prevention by physical activity].
    Ma Z; Li S; Zhu X; Gong H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):124-8. PubMed ID: 17333905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].
    Bahlous A; Kalai E; Hadj Salah M; Bouzid K; Zerelli L
    Tunis Med; 2006 Nov; 84(11):751-7. PubMed ID: 17294906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.
    Stepan JJ; Alenfeld F; Boivin G; Feyen JH; Lakatos P
    Endocr Regul; 2003 Dec; 37(4):225-38. PubMed ID: 15106819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of transient changes in trabecular bone remodeling activation.
    Weinhold PS; Gilbert JA; Woodard JC
    Bone; 1994; 15(5):577-84. PubMed ID: 7980969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A theoretical analysis of the changes in basic multicellular unit activity at menopause.
    Hernandez CJ; Beaupré GS; Carter DR
    Bone; 2003 Apr; 32(4):357-63. PubMed ID: 12689678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of remodeling parameter sensitivity--assessed by a computer simulation model.
    Thomsen JS; Mosekilde L; Mosekilde E
    Bone; 1996 Nov; 19(5):505-11. PubMed ID: 8922650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brief communication: Bone remodeling rates in Pleistocene humans are not slower than the rates observed in modern populations: A reexamination of Abbott et al. (1996).
    Streeter M; Stout S; Trinkaus E; Burr D
    Am J Phys Anthropol; 2010 Feb; 141(2):315-8. PubMed ID: 19927371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chaos in the discrete-time algorithm for bone-density remodeling rate equations.
    Cowin SC; Arramon YP; Luo GM; Sadegh AM
    J Biomech; 1993 Sep; 26(9):1077-89. PubMed ID: 8408090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between absence of bone remodeling compartment canopies, reversal phase arrest, and deficient bone formation in post-menopausal osteoporosis.
    Andersen TL; Hauge EM; Rolighed L; Bollerslev J; Kjærsgaard-Andersen P; Delaisse JM
    Am J Pathol; 2014 Apr; 184(4):1142-1151. PubMed ID: 24508231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone remodeling and structural optimization.
    Harrigan TP; Hamilton JJ
    J Biomech; 1994 Mar; 27(3):323-8. PubMed ID: 8051192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.